FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4281384293> ?p ?o ?g. }

• W4281384293 endingPage "2939" @default.
• W4281384293 startingPage "2939" @default.
• W4281384293 abstract "Chemotherapy-induced peripheral neuropathy (CIPN) is a frequent and dose-limiting adverse side effect of treatment. CIPN affects the oncological prognosis of patients, as well as their quality of life. To date, no specific pharmacological therapy has demonstrated effectiveness in preventing CIPN. Accumulating preclinical evidence suggests that renin-angiotensin system (RAS) inhibitors may have neuroprotective effects. One hundred and twenty patients were included in this observational study and were followed from the beginning of their neurotoxic chemotherapy schedule until their final assessment, at least one month after its cessation. The National Cancer Institute’s common toxicity criteria 4.0 (NCI-CTC 4.0) were used to grade the severity of adverse events. Follow-ups also included electrochemical skin conductance and scales for pain, quality of life and disability. Among patients receiving a platinum-based regimen, the mean grade of sensory neuropathy (NCI-CTC 4.0) was significantly lower in the RAS inhibitor group after the end of their anticancer treatment schedule. Because of the observational design of the study, patients in the RAS inhibitor group cumulated comorbidities at risk of developing CIPN. Randomized controlled trials in platinum-based regimens would be worth conducting in the future to confirm the neuroprotective potential of RAS inhibitors during chemotherapy." @default.
• W4281384293 created "2022-05-25" @default.
• W4281384293 creator A5013816563 @default.
• W4281384293 creator A5027554290 @default.
• W4281384293 creator A5030152039 @default.
• W4281384293 creator A5055576167 @default.
• W4281384293 creator A5064740357 @default.
• W4281384293 creator A5065363309 @default.
• W4281384293 creator A5066874289 @default.
• W4281384293 creator A5072009869 @default.
• W4281384293 creator A5073120764 @default.
• W4281384293 creator A5084463275 @default.
• W4281384293 creator A5090829585 @default.
• W4281384293 date "2022-05-23" @default.
• W4281384293 modified "2023-09-26" @default.
• W4281384293 title "Renin-Angiotensin-System Inhibitors for the Prevention of Chemotherapy-Induced Peripheral Neuropathy: OncoToxSRA, a Preliminary Cohort Study" @default.
• W4281384293 cites W1492650228 @default.
• W4281384293 cites W2004965421 @default.
• W4281384293 cites W2028439883 @default.
• W4281384293 cites W2038862800 @default.
• W4281384293 cites W2090662855 @default.
• W4281384293 cites W2112092094 @default.
• W4281384293 cites W2114458368 @default.
• W4281384293 cites W2153372656 @default.
• W4281384293 cites W2155412494 @default.
• W4281384293 cites W2162052305 @default.
• W4281384293 cites W2222698370 @default.
• W4281384293 cites W2254429971 @default.
• W4281384293 cites W2292343278 @default.
• W4281384293 cites W2560322684 @default.
• W4281384293 cites W2613929012 @default.
• W4281384293 cites W2753461289 @default.
• W4281384293 cites W2754729322 @default.
• W4281384293 cites W2801946481 @default.
• W4281384293 cites W2883486569 @default.
• W4281384293 cites W2887771983 @default.
• W4281384293 cites W2942458736 @default.
• W4281384293 cites W2942910426 @default.
• W4281384293 cites W2981826647 @default.
• W4281384293 cites W2982063755 @default.
• W4281384293 cites W2982135574 @default.
• W4281384293 cites W3042992354 @default.
• W4281384293 cites W3131211834 @default.
• W4281384293 cites W3132509757 @default.
• W4281384293 cites W3135644563 @default.
• W4281384293 cites W3164240824 @default.
• W4281384293 cites W3186160686 @default.
• W4281384293 cites W3211488171 @default.
• W4281384293 doi "https://doi.org/10.3390/jcm11102939" @default.
• W4281384293 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35629066" @default.
• W4281384293 hasPublicationYear "2022" @default.
• W4281384293 type Work @default.
• W4281384293 citedByCount "3" @default.
• W4281384293 countsByYear W42813842932022 @default.
• W4281384293 countsByYear W42813842932023 @default.
• W4281384293 crossrefType "journal-article" @default.
• W4281384293 hasAuthorship W4281384293A5013816563 @default.
• W4281384293 hasAuthorship W4281384293A5027554290 @default.
• W4281384293 hasAuthorship W4281384293A5030152039 @default.
• W4281384293 hasAuthorship W4281384293A5055576167 @default.
• W4281384293 hasAuthorship W4281384293A5064740357 @default.
• W4281384293 hasAuthorship W4281384293A5065363309 @default.
• W4281384293 hasAuthorship W4281384293A5066874289 @default.
• W4281384293 hasAuthorship W4281384293A5072009869 @default.
• W4281384293 hasAuthorship W4281384293A5073120764 @default.
• W4281384293 hasAuthorship W4281384293A5084463275 @default.
• W4281384293 hasAuthorship W4281384293A5090829585 @default.
• W4281384293 hasBestOaLocation W42813842931 @default.
• W4281384293 hasConcept C126322002 @default.
• W4281384293 hasConcept C134018914 @default.
• W4281384293 hasConcept C143998085 @default.
• W4281384293 hasConcept C159110408 @default.
• W4281384293 hasConcept C197934379 @default.
• W4281384293 hasConcept C23131810 @default.
• W4281384293 hasConcept C25498285 @default.
• W4281384293 hasConcept C2776694085 @default.
• W4281384293 hasConcept C2779289229 @default.
• W4281384293 hasConcept C2779901536 @default.
• W4281384293 hasConcept C2779951463 @default.
• W4281384293 hasConcept C2781413609 @default.
• W4281384293 hasConcept C555293320 @default.
• W4281384293 hasConcept C71924100 @default.
• W4281384293 hasConcept C98274493 @default.
• W4281384293 hasConceptScore W4281384293C126322002 @default.
• W4281384293 hasConceptScore W4281384293C134018914 @default.
• W4281384293 hasConceptScore W4281384293C143998085 @default.
• W4281384293 hasConceptScore W4281384293C159110408 @default.
• W4281384293 hasConceptScore W4281384293C197934379 @default.
• W4281384293 hasConceptScore W4281384293C23131810 @default.
• W4281384293 hasConceptScore W4281384293C25498285 @default.
• W4281384293 hasConceptScore W4281384293C2776694085 @default.
• W4281384293 hasConceptScore W4281384293C2779289229 @default.
• W4281384293 hasConceptScore W4281384293C2779901536 @default.
• W4281384293 hasConceptScore W4281384293C2779951463 @default.
• W4281384293 hasConceptScore W4281384293C2781413609 @default.
• W4281384293 hasConceptScore W4281384293C555293320 @default.
• W4281384293 hasConceptScore W4281384293C71924100 @default.
• W4281384293 hasConceptScore W4281384293C98274493 @default.

• next